Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.
Luzzago S, Piccinelli ML, Marvaso G, Laukhtina E, Miura N, Schuettfort VM, Mori K, Aydh A, Ferro M, Mistretta FA, Fusco N, Petralia G, Jereczek-Fossa BA, Shariat SF, Karakiewicz PI, de Cobelli O, Musi G. Luzzago S, et al. Among authors: fusco n. World J Urol. 2022 Feb;40(2):443-451. doi: 10.1007/s00345-021-03864-6. Epub 2021 Oct 23. World J Urol. 2022. PMID: 34687344
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates.
Luzzago S, Piccinelli ML, Mistretta FA, Bianchi R, Cozzi G, Di Trapani E, Cioffi A, Catellani M, Fontana M, Jannello LMI, Botticelli FMG, Marvaso G, Alessi S, Pricolo P, Ferro M, Matei DV, Jereczek-Fossa BA, Fusco N, Petralia G, de Cobelli O, Musi G. Luzzago S, et al. Among authors: fusco n. BJU Int. 2022 Apr;129(4):524-533. doi: 10.1111/bju.15623. Epub 2021 Nov 10. BJU Int. 2022. PMID: 34687137 Free article.
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer.
Piccinelli ML, Luzzago S, Marvaso G, Laukhtina E, Miura N, Schuettfort VM, Mori K, Colombo A, Ferro M, Mistretta FA, Fusco N, Petralia G, Jereczek-Fossa BA, Shariat SF, Karakiewicz PI, de Cobelli O, Musi G. Piccinelli ML, et al. Among authors: fusco n. World J Urol. 2022 Jun;40(6):1447-1454. doi: 10.1007/s00345-022-03983-8. Epub 2022 Mar 26. World J Urol. 2022. PMID: 35347414 Free PMC article.
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women.
Leonardi MC, Cormio CF, Frassoni S, Dicuonzo S, Fodor C, Intra M, Zerella MA, Morra A, Cattani F, Comi S, Fusco N, Zaffaroni M, Galimberti V, Veronesi P, Dellapasqua S, De Lorenzi F, Ivaldi GB, Bagnardi V, Orecchia R, Rojas DP, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: fusco n. Radiother Oncol. 2022 Dec;177:71-80. doi: 10.1016/j.radonc.2022.10.025. Epub 2022 Oct 28. Radiother Oncol. 2022. PMID: 36377094
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
Luzzago S, Colombo A, Mistretta FA, Alessi S, Di Trapani E, Summers PE, Piccinelli ML, Raimondi S, Vignati S, Clemente A, Rosati E, di Meglio L, d'Ascoli E, Scarabelli A, Zugni F, Belmonte M, Maggioni R, Ferro M, Fusco N, de Cobelli O, Musi G, Petralia G. Luzzago S, et al. Among authors: fusco n. Radiology. 2023 Nov;309(2):e223349. doi: 10.1148/radiol.223349. Radiology. 2023. PMID: 37987657
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study.
Volpe S, Zaffaroni M, Piperno G, Vincini MG, Zerella MA, Mastroleo F, Cattani F, Fodor CI, Bellerba F, Bonaldi T, Bonizzi G, Ceci F, Cremonesi M, Fusco N, Gandini S, Garibaldi C, Torre D, Noberini R, Petralia G, Spaggiari L, Venetis K, Orecchia R, Casiraghi M, Jereczek-Fossa BA. Volpe S, et al. Among authors: fusco n. BMC Cancer. 2023 Dec 15;23(1):1236. doi: 10.1186/s12885-023-11701-9. BMC Cancer. 2023. PMID: 38102575 Free PMC article.
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperative Surgical Margins: A Clinical Trial Protocol.
Musi G, Mistretta FA, de Cobelli O, Bellin A, Vago GG, Pravettoni G, Bottero D, Piccinelli ML, Ferro M, Ivanova M, Petralia G, Marvaso G, Jereczek-Fossa BA, Bagnardi V, Renne G, Fusco N, Luzzago S. Musi G, et al. Among authors: fusco n. Eur Urol Open Sci. 2024 Feb 3;61:1-9. doi: 10.1016/j.euros.2024.01.006. eCollection 2024 Mar. Eur Urol Open Sci. 2024. PMID: 38333626 Free PMC article.
Tools to Guide Radiation Oncologists in the Management of DCIS.
Leonardi MC, Zerella MA, Lazzeroni M, Fusco N, Veronesi P, Galimberti VE, Corso G, Dicuonzo S, Rojas DP, Morra A, Gerardi MA, Lorubbio C, Zaffaroni M, Vincini MG, Orecchia R, Jereczek-Fossa BA, Magnoni F. Leonardi MC, et al. Among authors: fusco n. Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795. Healthcare (Basel). 2024. PMID: 38610216 Free PMC article. Review.
325 results